What is Acasti Pharma Inc. (ACST)?

Acasti Pharma Inc. (ACST) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of ACST?

The current price of ACST is $3.37. Prices are updated in real time on Stocks360.

What is ACST's price-to-earnings (PE) ratio?

ACST's trailing twelve-month PE ratio is -2.88, based on current price and earnings per share data available on Stocks360.

What is ACST's market capitalization?

ACST's market capitalization is $34,171,463.00, placing it in the small-cap tier.

Acasti Pharma Inc. (ACST)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$3.37

Market Cap

$34.17M

PE (TTM)

-2.88

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.52

Day Range

$3.20 – $3.45

52-wk Range

$1.98 – $3.60

Avg Volume

N/A

Volume

27.68K

Acasti Pharma Inc. (ACST) is a publicly traded company in the Healthcare sector. Latest price: $3.37. Market cap $34.17M. Trailing PE -2.88. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 11, 2024

EPS $-0.19 vs est. $-0.45

Beat by $0.26

Proprietary Signals

Signal snapshot temporarily unavailable.

About Acasti Pharma Inc.

Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Laval.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-2.88×
P/S (TTM)	0.00×
P/B	1.21×
PEG	0.02×
P/FCF (TTM)	-3.32×
EV / EBITDA	-3.64×
EV / Sales	0.00×
Earnings Yield	-37.66%
Free Cash Flow Yield	-30.11%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$20.42M
Net Income (TTM)	-$12.87M
Free Cash Flow (TTM)	-$10.29M
Net Debt	-$13.76M
Working Capital	$13.08M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-36.56%
Return on Invested Capital	-11.51%